Reimbursement: Brace Yourself for Lower Medicare Part B Drug Payments

Why This Topic Matters

The proposal could affect how Medicare pays for Part B drugs, including payment methodology, beneficiary cost-sharing, and broader value-based purchasing efforts. Readers who manage Medicare reimbursement or specialty drug administration need to understand the scope of the proposed changes and the concerns being raised before implementation.

Article Sections

1. CMS Wants You to Change Your Part B Prescribing

   Introduces the proposed Medicare Part B drug payment model and explains the general policy goals CMS says it is trying to test. The section frames the proposal in the context of Medicare payment reform and outpatient drug administration.

2. Get Ready for 6 New Test Models

   Outlines the six broad categories of alternative payment and decision-support approaches CMS proposes to evaluate. The section describes the types of models being considered and the general timing noted in the article.

3. But Not Everyone is Happy

   Summarizes opposition from oncology, hospital, and pharmaceutical stakeholders. The section also notes the comment period and references to the proposed rule and related CMS materials.